Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 341 clinical trials
HidraWear AX HS Study

The product, HidraWear AX is and adhesive free wound dressing system for the every day home care of Hidradenitis Suppurativa (HS), a debilitating disease of the skin for which there are limited wound dressing products. This is a study to assess the use HidraWear Ax vs current product and method …

hidradenitis
  • 0 views
  • 05 Aug, 2020
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

biomarker analysis
ipilimumab
systemic therapy
hepatitis b antigen
non-small cell lung cancer
  • 0 views
  • 16 Feb, 2024
  • 9 locations
Physiological Changes Induced Through MEP Conditioning in People With SCI

Research participants will be asked to stand, sit, and walk during the study sessions. Electrodes are placed on the skin over leg muscles for monitoring muscle activity. For examining brain-to-muscle connections, the study team will use transcranial magnetic stimulation.

nervous system
traumatic brain injury
weakness
nervous
spasticity
  • 0 views
  • 16 Feb, 2024
  • 1 location
Dose Escalation of DF6002 in Patients With Advanced Solid Tumors and Expansion in Selected Indications

This study is a Phase 1/2, open-label, dose-escalation study with a consecutive parallel-group efficacy expansion study, designed to determine the safety, tolerability, PK, pharmacodynamics, and preliminary anti-tumor activity of DF6002 as monotherapy and in combination with pembrolizumab.

squamous cell carcinoma of the skin
lung cancer
advanced urothelial carcinoma
prostate cancer
urothelial carcinoma
  • 0 views
  • 05 Aug, 2020
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

Participants will get once daily injections of either NNC0472-0147 or insulin glargine for a treatment period of fourteen days. The injections will be given under the skin (subcutaneously, s.c.) of the left thigh. Participants will be in the study for about 7 weeks. There will be 15 visits with the …

oophorectomy
type 2 diabetes mellitus
bilateral oophorectomy
cholesterol level
low density lipoprotein
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Trialx: AI-Supported E-Learning for Pressure Injury Prevention  

Brief SummaryPressure injuries are damage to the skin and underlying tissue that may occur in patients who stay in bed for long periods, have limited mobility or use medical devices. These injuries are often preventable.

Accepts healthy volunteers
  • 0 views
  • 23 Jun, 2026
  • 1 location
Deep Brain Stimulation Surgery for Movement Disorders

DBS uses a battery-powered device called a neurostimulator (like a pacemaker) that is placed under the skin in the chest. It is used to stimulate the areas of the brain that affect movement. Stimulating these areas helps to block the nerve signals that cause abnormal movements.

  • 0 views
  • 24 Nov, 2025
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis (TOP-N53-02)

The main goal of this clinical trial is to learn about how safe the new drug TOP-N53 solution is when it is applied to open wounds on the fingertip (digital ulcers) in people with an uncommon illness that results in hard, thickened areas of skin and additional problems with internal …

  • 0 views
  • 02 May, 2025
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

This study will investigate the effects of atezolizumab on select cancer types in people whose analysis of tumour DNA and RNA indicates they may be sensitive to atezolizumab. This study aims to determine if the information from the cancer genome analysis corresponds with the effects of atezolizumab on individuals and …

transcriptome analysis
g-csf
absolute neutrophil count
international normalized ratio
lung cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

This is a phase I, open-label, non-randomized study that will enroll pediatric and young adult research participants with relapsed or refractory non-CNS solid tumors to evaluate the safety, feasibility, and efficacy of administering T cell products derived from the research participant's blood that have been genetically modified to express a …

cetuximab
biotherapy
solid tumor
trastuzumab
stem cell infusion
  • 0 views
  • 16 Feb, 2024
  • 1 location